A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis
about
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis.Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment.VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease.Recruiting specialized macrophages across the borders to restore brain functions.Cannabinoids therapeutic use: what is our current understanding following the introduction of THC, THC:CBD oromucosal spray and others?Phytocannabinoids: a unified critical inventory.Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy.The Endocannabinoid System and Oligodendrocytes in Health and Disease
P2860
Q30670447-60AA5B9D-41C6-43F1-99C9-776124A731E6Q34522740-AB05831B-3B04-4566-B1D6-8723FD43D923Q37105051-2DBB37A9-D9E3-4610-BF2D-4A637585DD59Q38250319-93F1568C-F7D6-484D-B72C-BA8F5A851390Q38748394-A539805A-0B3C-4BD5-9EF3-9B58E392FD45Q38976904-3AF2FB18-544F-4374-ABF8-39BF0316004CQ45288114-B9BBB64B-FA7B-4BA2-A66F-5E61DE49610FQ48095829-8030ACEB-B6E1-4168-85C1-3A1E05FCD147Q49433973-F1B1243C-4269-40DA-B4C2-71285F5C2115Q52678835-3BB4F618-3A7F-459A-ACAB-CD69C4517DF7Q58707257-CEA48ED6-BDC8-4029-BCFD-9E1687A792B2
P2860
A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@ast
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@en
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@nl
type
label
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@ast
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@en
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@nl
prefLabel
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@ast
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@en
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@nl
P2093
P2860
P50
P3181
P1433
P1476
A cannabigerol derivative supp ...... l autoimmune encephalomyelitis
@en
P2093
Carmen Guaza
Carmen Navarrete
Irene Cantarero
Juan A Collado
María L Bellido
Miriam Mecha
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0094733
P407
P577
2014-04-11T00:00:00Z